These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 21726837)
41. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study. Scirica BM; Sabatine MS; Morrow DA; Gibson CM; Murphy SA; Wiviott SD; Giugliano RP; McCabe CH; Cannon CP; Braunwald E J Am Coll Cardiol; 2006 Jul; 48(1):37-42. PubMed ID: 16814646 [TBL] [Abstract][Full Text] [Related]
42. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Keltai M; Tonelli M; Mann JF; Sitkei E; Lewis BS; Hawken S; Mehta SR; Yusuf S; Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):312-8. PubMed ID: 17446813 [TBL] [Abstract][Full Text] [Related]
43. Clopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarction. Zeymer U; Gitt AK; Zahn R; Jünger C; Bauer T; Köth O; Heer T; Wienbergen H; Gottwik M; Senges J Acute Card Care; 2008; 10(1):43-8. PubMed ID: 17924233 [TBL] [Abstract][Full Text] [Related]
44. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction. Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506 [TBL] [Abstract][Full Text] [Related]
45. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Berger PB; Bhatt DL; Fuster V; Steg PG; Fox KA; Shao M; Brennan DM; Hacke W; Montalescot G; Steinhubl SR; Topol EJ; Circulation; 2010 Jun; 121(23):2575-83. PubMed ID: 20516378 [TBL] [Abstract][Full Text] [Related]
46. Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome. Lemesle G; Delhaye C; Sudre A; Broucqsault D; Rosey G; Bauters C; Lablanche JM Am Heart J; 2009 Feb; 157(2):375-82. PubMed ID: 19185648 [TBL] [Abstract][Full Text] [Related]
47. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial. Yong G; Rankin J; Ferguson L; Thom J; French J; Brieger D; Chew DP; Dick R; Eccleston D; Hockings B; Walters D; Whelan A; Eikelboom JW Am Heart J; 2009 Jan; 157(1):60.e1-9. PubMed ID: 19081397 [TBL] [Abstract][Full Text] [Related]
48. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM; Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967 [TBL] [Abstract][Full Text] [Related]
49. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation. Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391 [TBL] [Abstract][Full Text] [Related]
50. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Maltais S; Perrault LP; Do QB Eur J Cardiothorac Surg; 2008 Jul; 34(1):127-31. PubMed ID: 18455412 [TBL] [Abstract][Full Text] [Related]
51. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM; Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803 [TBL] [Abstract][Full Text] [Related]
52. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557 [TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770 [TBL] [Abstract][Full Text] [Related]
54. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels. Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169 [TBL] [Abstract][Full Text] [Related]
55. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S; Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255 [TBL] [Abstract][Full Text] [Related]
56. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Wiviott SD; Trenk D; Frelinger AL; O'Donoghue M; Neumann FJ; Michelson AD; Angiolillo DJ; Hod H; Montalescot G; Miller DL; Jakubowski JA; Cairns R; Murphy SA; McCabe CH; Antman EM; Braunwald E; Circulation; 2007 Dec; 116(25):2923-32. PubMed ID: 18056526 [TBL] [Abstract][Full Text] [Related]
57. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. van der Linden J; Lindvall G; Sartipy U Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831 [TBL] [Abstract][Full Text] [Related]
58. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study). Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470 [TBL] [Abstract][Full Text] [Related]
59. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. Yusuf S; Zhao F; Mehta SR; Chrolavicius S; Tognoni G; Fox KK; N Engl J Med; 2001 Aug; 345(7):494-502. PubMed ID: 11519503 [TBL] [Abstract][Full Text] [Related]
60. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin. Ouattara A; Bouzguenda H; Le Manach Y; Léger P; Mercadier A; Leprince P; Bonnet N; Montalescot G; Riou B; Coriat P Eur Heart J; 2007 Apr; 28(8):1025-32. PubMed ID: 17431000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]